Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003-2022. [PDF]
Nuwamanya Y +10 more
europepmc +1 more source
Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States. [PDF]
Yi Z, Owusu-Edusei K, Elbasha E.
europepmc +1 more source
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults. [PDF]
Rey-Ares L +6 more
europepmc +1 more source
Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS). [PDF]
Oliveira M +7 more
europepmc +1 more source
Radiographically confirmed pneumonia in Malawian children and associated pneumococcal carriage after introduction of the 13-valent pneumococcal conjugate vaccine. [PDF]
Mzumara G +13 more
europepmc +1 more source
A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host [PDF]
Chavez, Sthefany M. +5 more
core +1 more source
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. [PDF]
Kobayashi M +10 more
europepmc +1 more source
A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015. [PDF]
Yen TA +9 more
europepmc +1 more source

